JPRN-UMIN000028914Completed未知
Safety assessment of oral intake of L-lysine.: Systematic review - Safety assessment of L-lysine
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
Temporary no observed adverse effect level (NOAEL) was determined 6000 mg / man / day.
Study Design
- Study Type
- Others,meta-analysis etc
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •We exclude studies that is not oral intake of L-lysine or not clinical study.
Investigators
Similar Trials
Recruiting
Unknown
Safety assessment of oral intake of Glycine: Systematic reviewJPRN-UMIN000042102Yokohama University of Pharmacy100
Completed
Phase 2
Dose-escalating, phase 2 study of oral lisdexamfetamine in adults with methamphetamine dependenceACTRN12615000391572St. Vincent's Hospital, Sydney20
Not yet recruiting
Unknown
Safety evaluation of long-term intake lactic acid bacteriahealthy adultJPRN-UMIN000052146Miura Clinic, Medical Corporation Kanonkai20
Not yet recruiting
Not Applicable
Safety assessment of oral intake of inositol:Systematic reviewJPRN-UMIN000030106Yokohama University of Pharmacy100
Completed
Not Applicable
Safety assessment of oral intake of L-Ornithine: Systematic reviewHuman who has received L-Ornithine by oralJPRN-UMIN000033371Yokohama University of Pharmacy100